In an effort to expedite the on-boarding process stipulated in Directive 2011/62/EU, the European Medicines Verification Organisation (EMVO) is circulating a letter of announcement to manufacturers, marketing authorisation holders and parallel traders with information material on how companies are to engage in the on-boarding portal. Further details can be accessed on the following EMVO platform: https://emvo-medicines.eu/
The MMA Academy is developing a new course in advanced regulatory sciences for medicinal products — and this week is dedicated to listening to you. Take a moment to share your views and help shape a programme that reflects real training needs. Complete this ?? Form and tell us what matters most to you. #DesignedWithTheRegulatoryCommunity